101 citations
- Novartis (Switzerland)CH5 papers
- Medical University of ViennaAT2 papers
- Université Paris CitéFR2 papers
- Assistance Publique – Hôpitaux de ParisFR1 paper
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y DigestivasES1 paper
- Florida CollegeUS1 paper
- Fred Hutch Cancer CenterUS1 paper
- Indiana UniversityUS1 paper
- Infection, Anti-microbiens, Modélisation, EvolutionFR1 paper
- InsermFR1 paper
- Instituto de Salud Carlos IIIES1 paper
- Janssen (United States)US1 paper
Showing stat.APShow all
3 papers · 1 filter
stat.AP2022★ 7 cited
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A. Di Prospero +5
Non-alcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD) and a disease with high unmet medical need. Platform trials provide great b…
stat.AP2012★ 18 cited
Longitudinal Functional Models with Structured Penalties
Madan G. Kundu, Jaroslaw Harezlak, Timothy W. Randolph
This paper addresses estimation in a longitudinal regression model for association between a scalar outcome and a set of longitudinally-collected functional covariates or predictor…
stat.AP2010★ 29 cited
Smoothed ANOVA with spatial effects as a competitor to MCAR in multivariate spatial smoothing
Yufen Zhang, James S. Hodges, Sudipto Banerjee
Rapid developments in geographical information systems (GIS) continue to generate interest in analyzing complex spatial datasets. One area of activity is in creating smoothed disea…